ANGELA RYERSON: Open Payments
NPI 1508636432 · NUTLEY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,611 in 145 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $1,318 · 2025 $2,611
Food & beverage: $2,512Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $611 |
| Galderma Laboratories, L.P. | 19 | $244 |
| Janssen Biotech, Inc. | 9 | $243 |
| Regeneron Healthcare Solutions, Inc. | 12 | $210 |
| GENZYME CORPORATION | 4 | $187 |
| Arcutis Biotherapeutics, Inc. | 4 | $172 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $148 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $137 |
| Incyte Corporation | 7 | $124 |
| Lilly USA, LLC | 6 | $109 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, Zoryve, RINVOQ, NEMLUVIO, OPZELURA, ILUMYA.
Industry payments across NJ — which companies pay providers there.
